课题基金 / 基金详情

Evolution of multidrug resistance in Acinetobacter baumannii

Evolution of multidrug resistance in Acinetobacter baumannii
鲍曼不动杆菌多重耐药性的演变
批准号:
8107146
负责人:
Mark D ADAMS
金额:
$32.14万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2015-08-31

项目摘要

项目成果

Mark D ADAMS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The emergence of multidrug resistance (MDR) in Acinetobacter baumannii has resulted in the designation of this Gram negative bacterium as a priority in Infectious Diseases. The long-term goal of this work is to understand the molecular basis for antibiotic resistance in A. baumannii and the role of mobile genetic elements in the evolution of resistance. Genes encoding antibiotic resistance determinants are frequently associated with mobile genetic elements in A. baumannii including insertions sequences (IS) and in MDR strains many resistance genes are co-located in a laterally transferred 'resistance island' (RI). Genome sequencing of closely related strains from the same hospital revealed variation in the complement of resistance genes that corresponded with differences in antimicrobial susceptibility pattern. The role of mobile genetic elements and other genetic changes in the evolution of antibiotic resistance will be explored through characterization of collections of strains from three recent A. baumannii outbreaks in unprecedented detail. The strategy is designed to identify genotypic variation among extensively drug resistant strains and phenotypic variation among genotypically similar or identical strains. These strain collections will enable consideration of genetic changes over time periods of weeks to months that are associated with changes in antibiotic resistance. Molecular sequencing typing will be used to establish broad patterns of relatedness among strains and to identify instances of variation in resistance phenotype over time by clone type. Whole-genome sequencing and gene expression analysis will provide detailed information about the presence, organization, and regulation of genes associated with resistance. The rate of mobilization of IS elements and changes in the RI will be determined through phylogenetic analysis. Although specific genes are known to contribute to resistance to certain antibiotics, it is also likely that high level resistance is the result of a combination of factors including drug inactivation, efflux, and target site modification. Analysis of diverse stains will lead to identification of alternative gene sets that lead to resistance. The outcome of this study will be a better understanding of how multidrug resistance evolves in a clinical setting. It will also result in a more complete view of the mechanisms that lead to antibiotic resistance in A. baumannii, which will assist in development of molecular diagnostic assays to inform selection of the most appropriate therapeutic regimen. PUBLIC HEALTH RELEVANCE: Public health relevance. Bacteria can evolve rapidly to evade killing by antibiotics. This project will determine the genetic changes that happen over short time periods leading to antibiotic resistance. These changes include exchange of resistance genes among isolates and activation of genes by mobile genetic elements. Knowledge of the mechanisms and frequency of genetic change will help in the design of strategies to detect antimicrobial resistance and select the best therapy for treatment of infections.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome Technologies Coordinating Center
  • 批准号:
    10571905
  • 项目类别:
  • 资助金额:
    $149.81万
  • 财政年份:
    2021
  • 负责人:
    Mark D ADAMS
  • 依托单位:
Genome Technologies Coordinating Center
  • 批准号:
    10213304
  • 项目类别:
  • 资助金额:
    $63.33万
  • 财政年份:
    2021
  • 负责人:
    Mark D ADAMS
  • 依托单位:
Genome Technologies Coordinating Center
  • 批准号:
    10408042
  • 项目类别:
  • 资助金额:
    $149.81万
  • 财政年份:
    2021
  • 负责人:
    Mark D ADAMS
  • 依托单位:
Modular Platform for Combinatorial Epigenome Manipulation
  • 批准号:
    10592628
  • 项目类别:
  • 资助金额:
    $73.47万
  • 财政年份:
    2018
  • 负责人:
    Mark D ADAMS
  • 依托单位:
海外基金